GJB4
Gap junction beta-4 protein
Also known as: CX30.3, CXB4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NTQ9
- Gene
- GJB4
- Ensembl
- ENSG00000189433
- Chromosome
- 1
- Canonical length
- 266 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Cell Junctions
OverviewNCBI Gene
This gene encodes a transmembrane connexin protein that is a component of gap junctions. Mutations in this gene have been associated with erythrokeratodermia variabilis, progressive symmetric erythrokeratoderma and hearing impairment. [provided by RefSeq, Dec 2009]
Canonical amino-acid sequenceUniProt
266 residues, UniProt reviewed canonical sequence.
>Q9NTQ9|GJB4
1 MNWAFLQGLL SGVNKYSTVL SRIWLSVVFI FRVLVYVVAA EEVWDDEQKD FVCNTKQPGC
61 PNVCYDEFFP VSHVRLWALQ LILVTCPSLL VVMHVAYREE RERKHHLKHG PNAPSLYDNL
121 SKKRGGLWWT YLLSLIFKAA VDAGFLYIFH RLYKDYDMPR VVACSVEPCP HTVDCYISRP
181 TEKKVFTYFM VTTAAICILL NLSEVFYLVG KRCMEIFGPR HRRPRCRECL PDTCPPYVLS
241 QGGHPEDGNS VLMKAGSAPV DAGGYPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GJB4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- skin: 59 nTPM
- urinary bladder: 7.4 nTPM
- epididymis: 5.2 nTPM
- gallbladder: 4.5 nTPM
- esophagus: 4.2 nTPM
- breast: 2.5 nTPM
Single-cell type
- ocular epithelial cells: 105 nCPM
- esophageal apical cells: 32 nCPM
- urothelial cells: 14 nCPM
- esophageal suprabasal cells: 14 nCPM
- prostatic hillock cells: 13 nCPM
- retinal pigment epithelial cells: 8.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.3 nTPM
- basal ganglia: 1.2 nTPM
- hippocampal formation: 1.2 nTPM
- white matter: 0.9 nTPM
- amygdala: 0.8 nTPM
- cerebellum: 0.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GJB4.
Disease | AllUniProt
Conditions GJB4 is implicated in, by any mechanism.
- Erythrokeratodermia variabilis et progressiva 2 (EKVP2) MIM:617524
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 134 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Erythrokeratodermia variabilis et progressiva 2
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.74
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.64
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell signaling
- gap junction-mediated intercellular transport
- olfactory behavior
- sensory perception of smell
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Connexin
- Connexin, N-terminal
- Connexin, conserved site
- Connexin, cysteine-rich domain
- Connexin, N-terminal domain superfamily
- Connexin
- Gap junction beta-4 protein (Cx30.3)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GJB4 as an antibody target. Whether an autoantibody or antibody against GJB4 could matter depends on whether native GJB4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GJB4 is annotated at the cell surface, where native GJB4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GJB4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...